Molecular Docking and Pharmacophore Modeling Studies of Fluorinated Benzamides as Potential CETP Inhibitors

Title:Molecular Docking and Pharmacophore Modeling Studies of Fluorinated Benzamides as Potential CETP Inhibitors

Volume: 13 Issue: 3

Author(s): Reema Abu Khalaf*, Sarah Al-Rawashdeh, Dima Sabbah and Ghassan Abu Sheikha

Affiliation:

• Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman,Jordan

Keywords: Cholesteryl ester transfer protein, docking, fluorinated benzamides, hyperlipidemia, inhibitors, molecular modeling.

Abstract: Background: Hyperlipidemia is one of the most common chronic diseases worldwide. Cholesteryl ester transfer protein (CETP) is a hydrophobic glycoprotein that facilitates the transfer of cholesteryl ester from the atheroprotective high-density lipoprotein (HDL) to the proatherogenic low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL).

Methods: In this work, synthesis and characterization of five fluorinated 3-benzylamino benzamides 8a-8c, 13a and 13b that target CETP activity were carried out.

Results: Benzamides 8b and 8a showed the highest CETP inhibitory activities with an IC50 of 0.75 μM and 4.1 μM respectively. It was found that the presence of p-OCF3 group (as in 8a-8c) enhances CETP inhibitory activity more than p-OCF2CHF2 (as in 13a and 13b) which could be attributed to the bulkiness of the tetrafluoroethoxy group hindering their proper orientation in the binding domain. Additionally m-F derivatives were found to have higher activity against CETP than p-F ones leaving the o-F analogues with the weakest anti-CETP bioactivity.

Conclusion: Ligand-based and structure-based drug design strategies confirm that hydrophobic interaction mediates ligand/protein complex formation and explains the activity of our verified molecules.

Cite this article as:

Khalaf Abu Reema*, Al-Rawashdeh Sarah, Sabbah Dima and Abu Sheikha Ghassan, Molecular Docking and Pharmacophore Modeling Studies of Fluorinated Benzamides as Potential CETP Inhibitors, Medicinal Chemistry 2017; 13 (3) . https://dx.doi.org/10.2174/1573406412666161104121042

DOI https://dx.doi.org/10.2174/1573406412666161104121042	Print ISSN 1573-4064
Publisher Name Bentham Science Publisher	Online ISSN 1875-6638